Cargando…
Microbiota: A potential orchestrator of antidiabetic therapy
The gut microbiota, as a ‘new organ’ of humans, has been identified to affect many biological processes, including immunity, inflammatory response, gut-brain neural circuits, and energy metabolism. Profound dysbiosis of the gut microbiome could change the metabolic pattern, aggravate systemic inflam...
Autores principales: | Liu, Bingyao, Zhang, Linlin, Yang, Hang, Zheng, Hongting, Liao, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911464/ https://www.ncbi.nlm.nih.gov/pubmed/36777348 http://dx.doi.org/10.3389/fendo.2023.973624 |
Ejemplares similares
-
A High Level of Circulating Valine Is a Biomarker for Type 2 Diabetes and Associated with the Hypoglycemic Effect of Sitagliptin
por: Liao, Xiaoyu, et al.
Publicado: (2019) -
Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy
por: Markelic, Milica, et al.
Publicado: (2023) -
Gut microbiota is a potential goalkeeper of dyslipidemia
por: Lei, Lirong, et al.
Publicado: (2022) -
Epigenetic control of mesenchymal stem cells orchestrates bone regeneration
por: Wang, Xiaofeng, et al.
Publicado: (2023) -
An Asian case of combined 17α-hydroxylase/17,20-lyase deficiency due to homozygous p.R96Q mutation: A case report and review of the literature
por: Liao, Qian, et al.
Publicado: (2022)